Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
190 hedge funds and large institutions have $3.2B invested in Medicines Co in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 73 increasing their positions, 58 reducing their positions, and 34 closing their positions.
88% more call options, than puts
Call options by funds: $42.6M | Put options by funds: $22.7M
26% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 58
22% more capital invested
Capital invested by funds: $2.62B → $3.2B (+$575M)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
1.79% more ownership
Funds ownership: 143.61% → 145.4% (+1.8%)
6% less funds holding
Funds holding: 202 → 190 (-12)
32% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
+$52M |
| 2 |
HM
HealthCor Management
New York
|
+$30.8M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$28.3M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$15.6M |
| 5 |
BlackRock
New York
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$36.6M |
| 2 |
TBC
Three Bays Capital
Boston,
Massachusetts
|
-$25.7M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$22.1M |
| 4 |
JP Morgan Chase
New York
|
-$20M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$15.3M |
MDCO Hedge Fund Activity: Q1 2018 in Review
190 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2018, worth a combined $3.2B — up 22% from $2.62B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of MDCO and 23 opened new positions — a net loss of 11 holders — while 58 trimmed existing stakes and 73 added.
The largest buyer was PointState Capital, adding an estimated $52M. The largest seller was AllianceBernstein, cutting an estimated $36.6M.
- 190 institutional investors held Medicines Co (MDCO) as of Q1 2018, down from 202 in Q4 2017.
- Funds reported $3.2B of Medicines Co stock for Q1 2018, up 22% quarter-over-quarter.
- 23 funds opened new Medicines Co positions in Q1 2018 and 34 closed out, a net change of -11 holders.
- The largest Medicines Co buyer in Q1 2018 was PointState Capital, an estimated $52M added.
- The largest Medicines Co seller in Q1 2018 was AllianceBernstein, an estimated $36.6M sold.
Based on aggregated 13F filings for Q1 2018.